Abstract
During the cholera epidemic which broke out in Nigeria at the end of December 1970, it was observed during in vitro sensitivitytests that the isolated species of Vibrio cholerae was sensitive to “Septrin” the Wellcome brand of co-trimoxazole. Tetracycline was the recommended drug of first choice. Permission was then sought from the Professor of Medicine to carry out a comparative trail of drugs in patients admitted to the Cholera Ward of the Lagos University Teaching Hospital. The trial began in January 1971 and it was prematurely terminated in April 1971.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barua, D. and Cvjetanovic, B. 1970: The Surveillance of Cholera. W.H.O. Chronicle 24, 41–46.
Oni, O.O.A. 1971: Cholera Epidemic in Ihadan, January to March 1971. Nig. Med. J. I. 229–233.
Salami, M.Y.L. 1972: Clinical and Epidemiological Aspects of Cholera Outbreak in Metropolitan Lagos. Nig. Med. J.2. 149.155.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mabadeje, A.F.B. (1976). Comparative Drug Trial in Cholera. In: Williams, J.D., Geddes, A.M. (eds) Parasites, Fungi, and Viruses. Chemotherapy, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3129-2_50
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3129-2_50
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3131-5
Online ISBN: 978-1-4684-3129-2
eBook Packages: Springer Book Archive